{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:27:42Z","timestamp":1793662062725,"version":"4.5.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Group B Streptococcus (GBS) is a leading cause of neonatal sepsis and meningitis and an important cause of invasive infections in pregnant and nonpregnant adults. Vaccines targeting capsule polysaccharides and common proteins are under development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using whole genome sequencing, a validated bioinformatics pipeline, and targeted antimicrobial susceptibility testing, we characterized 6340 invasive GBS isolates recovered during 2015\u20132017 through population-based Active Bacterial Core surveillance (ABCs) in 8 states.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six serotypes accounted for 98.4% of isolates (21.8% Ia, 17.6% V, 17.1% II, 15.6% III, 14.5% Ib, 11.8% IV). Most (94.2%) isolates were in 11 clonal complexes (CCs) comprised of multilocus sequence types identical or closely related to sequence types 1, 8, 12, 17, 19, 22, 23, 28, 88, 452, and 459. Fifty-four isolates (0.87%) had point mutations within pbp2x associated with nonsusceptibility to 1 or more \u03b2-lactam antibiotics. Genes conferring resistance to macrolides and\/or lincosamides were found in 56% of isolates; 85.2% of isolates had tetracycline resistance genes. Two isolates carrying vanG were vancomycin nonsusceptible (minimum inhibitory concentration = 2 \u00b5g\/mL). Nearly all isolates possessed capsule genes, 1\u20132 of the 3 main pilus gene clusters, and 1 of 4 homologous alpha\/Rib family determinants. Presence of the hvgA virulence gene was primarily restricted to serotype III\/CC17 isolates (465 isolates), but 8 exceptions (7 IV\/CC452 and 1 IV\/CC17) were observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This first comprehensive, population-based quantitation of strain features in the United States suggests that current vaccine candidates should have good coverage. The \u03b2-lactams remain appropriate for first-line treatment and prophylaxis, but emergence of nonsusceptibility warrants ongoing monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaa151","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T15:11:07Z","timestamp":1581606667000},"page":"1004-1013","source":"Crossref","is-referenced-by-count":103,"title":["Multistate, Population-Based Distributions of Candidate Vaccine Targets, Clonal Complexes, and Resistance Features of Invasive Group B Streptococci Within the United States, 2015\u20132017"],"prefix":"10.1093","volume":"72","author":[{"given":"Lesley","family":"McGee","sequence":"first","affiliation":[{"name":"Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopio","family":"Chochua","sequence":"additional","affiliation":[{"name":"Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongya","family":"Li","sequence":"additional","affiliation":[{"name":"IHRC Inc, Contractor to Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saundra","family":"Mathis","sequence":"additional","affiliation":[{"name":"IHRC Inc, Contractor to Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Rivers","sequence":"additional","affiliation":[{"name":"Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Metcalf","sequence":"additional","affiliation":[{"name":"Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Ryan","sequence":"additional","affiliation":[{"name":"California Emerging Infections Program, Oakland, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Alden","sequence":"additional","affiliation":[{"name":"Colorado Department of Public Health and Environment, Denver, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M","family":"Farley","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Atlanta, Georgia, USA"},{"name":"Atlanta Veterans Affairs Medical Center, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee H","family":"Harrison","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Snippes Vagnone","sequence":"additional","affiliation":[{"name":"Minnesota Department of Health, Saint Paul, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Lynfield","sequence":"additional","affiliation":[{"name":"Minnesota Department of Health, Saint Paul, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Smelser","sequence":"additional","affiliation":[{"name":"New Mexico Department of Public Health, Santa Fe, New Mexico, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Muse","sequence":"additional","affiliation":[{"name":"New York State Department of Health, Albany, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann R","family":"Thomas","sequence":"additional","affiliation":[{"name":"Oregon Department of Human Services, Portland, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Schrag","sequence":"additional","affiliation":[{"name":"Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard W","family":"Beall","sequence":"additional","affiliation":[{"name":"Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,15]]},"reference":[{"key":"2021031811100955400_CIT0001","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/cid\/cix656","article-title":"Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses","volume":"65","author":"Madrid","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2021031811100955400_CIT0002","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00049-18","article-title":"Perinatal Streptococcus agalactiae epidemiology and surveillance targets","volume":"31","author":"Furfaro","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"2021031811100955400_CIT0003","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jamainternmed.2018.7269","article-title":"Epidemiology of invasive group B streptococcal infections among nonpregnant adults in the United States, 2008\u20132016","volume":"179","author":"Francois Watkins","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2021031811100955400_CIT0004","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1016\/j.vaccine.2012.11.056","article-title":"Intrapartum. antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine","volume":"31","author":"Schrag","year":"2013","journal-title":"Vaccine"},{"key":"2021031811100955400_CIT0005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamapediatrics.2018.4826","article-title":"Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance","volume":"173","author":"Nanduri","year":"2019","journal-title":"JAMA Pediatr"},{"key":"2021031811100955400_CIT0006","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/AAC.00185-08","article-title":"First molecular characterization of group B streptococci with reduced penicillin susceptibility","volume":"52","author":"Kimura","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2021031811100955400_CIT0007","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1128\/AAC.00461-08","article-title":"Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics","volume":"52","author":"Dahesh","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2021031811100955400_CIT0008","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/jac\/dkv022","article-title":"Classification of group B streptococci with reduced \u03b2-lactam susceptibility (GBS-RBS) based on the amino acid substitutions in PBPs","volume":"70","author":"Kimura","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2021031811100955400_CIT0009","doi-asserted-by":"crossref","first-page":"574.e7","DOI":"10.1016\/j.cmi.2017.02.021","article-title":"Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA","volume":"23","author":"Metcalf","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2021031811100955400_CIT0010","article-title":"Prevention of early-onset group B streptococcal disease in newborns","author":"American College of Obstetricians and Gynecologists","year":"2019"},{"key":"2021031811100955400_CIT0011","doi-asserted-by":"crossref","first-page":"e0120035","DOI":"10.1371\/journal.pone.0120035","article-title":"Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing, China","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"2021031811100955400_CIT0012","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MPG.0000000000000928","article-title":"Influence of intrapartum antibiotic prophylaxis for group B Streptococcus on gut microbiota in the first month of life","volume":"62","author":"Corvaglia","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021031811100955400_CIT0013","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1128\/IAI.73.5.3096-3103.2005","article-title":"Structural and genetic diversity of group B Streptococcus capsular polysaccharides","volume":"73","author":"Cieslewicz","year":"2005","journal-title":"Infect Immun"},{"key":"2021031811100955400_CIT0014","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1017\/S0950268810001275","article-title":"Emergence of group B Streptococcus serotype IV in women of child-bearing age in Ireland","volume":"139","author":"Kiely","year":"2011","journal-title":"Epidemiol Infect"},{"key":"2021031811100955400_CIT0015","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3201\/eid1904.121572","article-title":"Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000\u20132010","volume":"19","author":"Ferrieri","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2021031811100955400_CIT0016","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3201\/eid2014.140759","article-title":"Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, Canada","volume":"21","author":"Teatero","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2021031811100955400_CIT0017","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1016\/j.vaccine.2019.04.039","article-title":"The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations","volume":"37","author":"Vekemans","year":"2019","journal-title":"Vaccine"},{"key":"2021031811100955400_CIT0018","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/jiz062","article-title":"A novel hexavalent capsular polysaccharide conjugate vaccine (GBS6) for the prevention of neonatal group B streptococcal infections by maternal immunization","volume":"220","author":"Buurman","year":"2019","journal-title":"J Infect Dis"},{"key":"2021031811100955400_CIT0019","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0001-2017","article-title":"Surface structures of group B Streptococcus important in human immunity","volume":"7","author":"Paoletti","year":"2019","journal-title":"Microbiol Spectr"},{"key":"2021031811100955400_CIT0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chom.2007.10.003","article-title":"Nonimmunodominant regions are effective as building blocks in a streptococcal fusion protein vaccine","volume":"2","author":"St\u00e5lhammar-Carlemalm","year":"2007","journal-title":"Cell Host Microbe"},{"key":"2021031811100955400_CIT0021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1128\/CVI.00643-14","article-title":"Survey of immunological features of the alpha-like proteins of Streptococcus agalactiae","volume":"22","author":"Maeland","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"2021031811100955400_CIT0022","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1126\/science.1109869","article-title":"Identification of a universal group B Streptococcus vaccine by multiple genome screen","volume":"309","author":"Maione","year":"2005","journal-title":"Science"},{"key":"2021031811100955400_CIT0023","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3201\/eid2109.141333","article-title":"Twenty years of active bacterial core surveillance","volume":"21","author":"Langley","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2021031811100955400_CIT0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/0471250953.bi1105s31","article-title":"Using the Velvet de novo assembler for short-read sequencing technologies","volume":"31","author":"Zerbino","year":"2010","journal-title":"Curr Protoc Bioinformatics"},{"key":"2021031811100955400_CIT0025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1128\/AAC.01310-13","article-title":"ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes","volume":"58","author":"Gupta","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021031811100955400_CIT0026","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1093\/jac\/dks261","article-title":"Identification of acquired antimicrobial resistance genes","volume":"67","author":"Zankari","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2021031811100955400_CIT0027","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1084\/jem.20092594","article-title":"The surface protein HvgA mediates group B Streptococcus hypervirulence and meningeal tropism in neonates","volume":"207","author":"Tazi","year":"2010","journal-title":"J Exp Med"},{"key":"2021031811100955400_CIT0028","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1086\/598217","article-title":"The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier","volume":"199","author":"van Sorge","year":"2009","journal-title":"J Infect Dis"},{"key":"2021031811100955400_CIT0029","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2958.2006.05225.x","article-title":"Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae","volume":"61","author":"Rosini","year":"2006","journal-title":"Mol Microbiol"},{"key":"2021031811100955400_CIT0030","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1128\/JB.186.5.1518-1530.2004","article-title":"eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data","volume":"186","author":"Feil","year":"2004","journal-title":"J Bacteriol"},{"key":"2021031811100955400_CIT0031","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/jac\/dkx077","article-title":"Cross-resistance to lincosamides, streptogramins A and pleuromutilins in Streptococcus agalactiae isolates from the USA","volume":"72","author":"Hawkins","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2021031811100955400_CIT0032","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/595564","article-title":"Preventing bacterial infections with pilus-based vaccines: the group B Streptococcus paradigm","volume":"199","author":"Margarit","year":"2009","journal-title":"J Infect Dis"},{"key":"2021031811100955400_CIT0033","doi-asserted-by":"crossref","first-page":"10278","DOI":"10.1073\/pnas.1106590108","article-title":"Structure-based approach to rationally design a chimeric protein for an effective vaccine against group B Streptococcus infections","volume":"108","author":"Nuccitelli","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021031811100955400_CIT0034","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1128\/IAI.64.9.3518-3523.1996","article-title":"Experimental vaccination against group B Streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha","volume":"64","author":"Larsson","year":"1996","journal-title":"Infect Immun"},{"key":"2021031811100955400_CIT0035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3343\/alm.2019.39.4.414","article-title":"First case in Korea of group B Streptococcus with reduced penicillin susceptibility harboring amino acid substitutions in penicillin-binding protein 2X","volume":"39","author":"Yi","year":"2019","journal-title":"Ann Lab Med"},{"key":"2021031811100955400_CIT0036","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/jac\/dkt060","article-title":"High cephalosporin resistance due to amino acid substitutions in PBP1A and PBP2X in a clinical isolate of group B Streptococcus","volume":"68","author":"Kimura","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2021031811100955400_CIT0037","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/22221751.2018.1557987","article-title":"Isolation of group B Streptococcus with reduced \u03b2-lactam susceptibility from pregnant women","volume":"8","author":"Moroi","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"2021031811100955400_CIT0038","doi-asserted-by":"crossref","first-page":"e01386","DOI":"10.1128\/mBio.01386-14","article-title":"vanG element insertions within a conserved chromosomal site conferring vancomycin resistance to Streptococcus agalactiae and Streptococcus anginosus","volume":"5","author":"Srinivasan","year":"2014","journal-title":"mBio"},{"key":"2021031811100955400_CIT0039","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"Scalable analysis of bacterial genome variation at the population level","volume":"11","author":"Jolley","year":"2010","journal-title":"BMC Bioinformatics"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa151\/32972251\/ciaa151.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/6\/1004\/36636317\/ciaa151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/6\/1004\/36636317\/ciaa151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T09:52:01Z","timestamp":1665827521000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/72\/6\/1004\/5736375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,15]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,2,15]]},"published-print":{"date-parts":[[2021,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa151","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,15]]},"published":{"date-parts":[[2020,2,15]]}}}